Thailand IVF Success Rate for Ages 35-40: Real Data & Age-Related Differences

AI Summary

Opening: Test Report Scenario

A 36-year-old woman, with AMH 1.0 ng/mL, FSH 9.8 mIU/mL, and a vaginal ultrasound showing an antral follicle count (AFC) of 4 on the left and 3 on the right. She holds the report and asks, "Given my current ovarian status, what are my chances of successfully having a baby through IVF in Thailand?" This question involves not just a simple number, but a comprehensive assessment of age, ovarian reserve, embryo chromosomal probability, laboratory screening capabilities, and physical tolerance.

A Direct Answer

Thailand IVF Success Rate for Ages 35-40: Real Range & Data Stratification

The live birth rate for the 35-40 age group reported by reputable Thai fertility centers generally falls within the 35%–55% range, depending on the specific age and individual conditions. A detailed breakdown by two-year increments is as follows:

Age	Live Birth Rate Reference Range	Implantation Rate per Single Embryo Transfer	Note
35–36 years	50% – 55%	45% – 52%	Those with normal ovarian reserve can reach the upper limit
37–38 years	42% – 48%	38% – 45%	Chromosomal abnormality rate begins to rise significantly
39–40 years	30% – 38%	28% – 36%	Euploid embryo proportion drops below 40%

The above data references the range for the 35-40 age group from the annual reports of several major Thai fertility centers (such as Jetanin, BNH, Vejthani, Phyathai 2, etc.). However, it is important to note that each institution has different patient selection criteria, making direct horizontal comparisons of limited value. It is more important to understand the determining factors behind the numbers.

L Interpretation of Test Indicators

Core Test Indicators Determining Success Rate: AMH, FSH, AFC & Embryo Chromosomes

Before IVF in Thailand, doctors will check four basic indicators that directly form the success rate prediction model:

• AMH (Anti-Müllerian Hormone) — Reflects ovarian reserve. For women aged 35-40, AMH > 1.5 ng/mL is ideal, 1.0–1.5 ng/mL indicates a mild decline, and < 1.0 ng/mL suggests significantly diminished reserve. For every 0.5 ng/mL decrease in AMH, the number of eggs retrieved decreases by approximately 2-3.
• FSH (Follicle-Stimulating Hormone) — A baseline value (on day 2-3 of menstruation) < 8 mIU/mL is excellent, 8–10 mIU/mL is borderline, and > 10 mIU/mL indicates diminished ovarian response. Elevated FSH is often accompanied by fewer eggs retrieved and poor synchrony of follicle development.
• Antral Follicle Count (AFC) — A total bilateral AFC > 10 is good, 6–10 is average, and < 6 indicates poor ovarian response. Interpreting AFC together with AMH provides higher accuracy than using a single indicator.
• Embryo Chromosomal Euploidy Rate — At age 35, about 55%–60% of embryos are chromosomally normal, which drops to 30%–35% by age 40. This is the deepest biological reason for the age-related decline in success rates. Even with normal ovarian reserve, advanced age leads to an increased proportion of aneuploid embryos.

D Differences Between Age Groups

Age 35 vs. Age 40: Core Sources of the Success Rate Gap

Even within the 35-40 age range, the success rate gap between age 35 and age 40 can be 15–20 percentage points, primarily due to three fundamental reasons:

Factor	35–36 years	39–40 years
Euploid Embryo Proportion	55% – 60%	30% – 38%
Average Number of Eggs Retrieved (at same AMH level)	10 – 14	6 – 9
Blastocyst Formation Rate	45% – 55%	30% – 42%
Endometrial Receptivity	Usually normal	May be decreased (ERA testing may be needed)
Cumulative Live Birth Rate (3 transfers)	70% – 80%	45% – 55%

Thai doctors' strategies differ significantly when treating 35-year-old versus 40-year-old patients. For age 35, there is a greater tendency towards fresh cycle transfer or single blastocyst transfer. For age 40, the emphasis is more on embryo accumulation, PGT-A screening, and frozen embryo transfer to reduce repeated failure caused by aneuploidy.

C Doctor's Perspective

How Doctors Assess Individual Success Rates: From Numbers to Decisions

In Thai fertility clinics, doctors do not directly give a success rate percentage. Instead, they explain it to patients using a "conditional probability" approach. The specific process is as follows:

1. Step 1: Predict the range of eggs retrieved based on AMH, AFC, and FSH. For example, with AMH 1.2 ng/mL and AFC 8, an estimated 6–10 eggs will be retrieved.
2. Step 2: Estimate the euploid embryo proportion based on age. At age 37, it's about 45%, meaning out of 6 cleavage-stage embryos, approximately 2–3 are chromosomally normal.
3. Step 3: Combine with the laboratory's blastocyst culture rate (most Thai centers have a blastocyst formation rate of about 40%–55%) to calculate the number of transferable embryos.
4. Step 4: Comprehensively assess the live birth rate per single transfer and the cumulative live birth rate. Doctors focus more on the "cumulative live birth rate," which is the probability of eventually achieving a successful live birth through multiple transfers.

From a doctor's perspective, the success rate is not a fixed number but a dynamically updated probability. With each step completed, the estimate for subsequent success is revised. This is why reputable Thai hospitals never promise a specific success rate, but instead emphasize that "each case is an individualized assessment."

E Differences Between Countries

Differences in Success Rates for Ages 35-40: Thailand vs. China and the USA

Based on clinical data, the live birth rate for the 35-40 age group in Thailand is roughly comparable to that of leading fertility centers in China (such as Peking University Third Hospital, CITIC Xiangya, Shanghai Ninth People's Hospital, etc.), with a difference of about ±5%. The real differences are reflected in the following aspects:

• Accessibility of PGT-A: Thailand has fewer regulatory restrictions on embryo genetic screening, allowing patients aged 35-40 more freedom to choose PGT-A. In China, the indications for PGT-A are more strictly controlled, making it difficult for many older patients to directly undergo PGT-A.
• Laboratory Quality Control: Some private Thai fertility centers have introduced next-generation time-lapse incubators, AI embryo assessment systems, and temperature-controlled clean labs, giving them a technical advantage in blastocyst culture and vitrification. The impact of laboratory differences on patients aged 35-40 is mainly seen in blastocyst culture failure rates and frozen embryo survival rates.
• Comparison with the USA: The live birth rate for ages 35-40 in the USA is about 40%–52%, slightly higher than in Thailand. However, this gap mainly stems from stricter donor egg management and a more mature genetic counseling system. The cost in the USA is 2–3 times that of Thailand, making the cost-benefit ratio incomparable for most self-funded families.

Practitioner's Observation: For the 35-40 age group, the real value of Thailand is not a "higher success rate," but a "lower threshold for PGT-A" and "greater cycle flexibility." For patients with declining AMH who still have follicles, Thai doctors are more willing to try personalized protocols like mild stimulation + PGT-A, rather than directly recommending donor eggs.

G The Most Easily Overlooked Details

The Most Easily Overlooked Details: Laboratory Stability & Embryologist Experience

When choosing a hospital in Thailand, patients often focus only on the "success rate number," overlooking a key variable: the laboratory quality control system. Even within the 35-39 age group, the blastocyst formation rate can differ by 8%–15% between different Thai hospitals. Reasons include:

• Batch-to-batch variation in culture media and replacement frequency
• Stability of incubator temperature, humidity, and gas concentration
• Embryologist's proficiency (especially in ICSI and vitrification)
• Whether the lab has an independent quality control process and third-party evaluation

Another easily overlooked detail is timing. For patients aged 35-40, ovarian reserve is on a declining trajectory, so the time from initial consultation to starting the cycle should not be too long. Thai hospitals typically require starting the cycle within 1–2 months after all test reports are ready. For patients with low AMH (<1.0 ng/mL), doctors may even recommend starting the cycle immediately without delay.

H The Most Common Pitfalls

The Most Common Pitfalls: Being Misled by "High Success Rate" Claims

The Thai IVF market has some common misleading claims that can create false expectations, especially for patients aged 35-40:

• Confusing "pregnancy rate" with "live birth rate" — Biochemical and clinical pregnancies still carry a risk of early miscarriage, which is about 15%–25% for ages 35-40. Looking only at the pregnancy rate overestimates the final probability of a live birth.
• Using data for those under 35 to represent the whole — Some hospitals advertise a "70% success rate," but this is actually data for the under-35 group and is irrelevant to the 35-40 age group.
• Ignoring the proportion of donor egg cycles — Some centers have higher live birth rates for older patients because they have a large proportion of donor egg cycles. The live birth rate difference between autologous and donor egg cycles can be over 30%.
• Promising "guaranteed success" or "money-back" — These plans often come with hidden conditions (e.g., AMH must be above a certain value, must use donor sperm/eggs, etc.), offering limited real benefit for autologous patients aged 35-40.

R Practitioner's Observation

Observations from a Consultant with 10 Years of Experience: Common Traits of Successful Cases Aged 35-40

After being involved in hundreds of IVF cases for patients aged 35-40 traveling to Thailand, several key factors influencing the final outcome have been identified. These are often more valuable references than a single success rate number:

• Ovarian reserve is more important than chronological age. A 38-year-old patient with AMH 2.3 ng/mL may have a better egg count and euploidy rate than a 35-year-old with AMH 0.8 ng/mL. Age is a reference, but AMH+AFC are the hard indicators.
• PGT-A is not a panacea, but it can prevent ineffective transfers. In the 35-40 age group, the live birth rate per single transfer after PGT-A screening is about 12%–18% higher than without screening, mainly due to a reduction in miscarriage rate. However, PGT-A cannot improve egg quality or reverse the age-related decline in euploidy.
• Psychological expectation management is a hidden necessity. Many patients come to Thailand with the goal of "success on the first try," but the average person aged 35-40 needs 1.5–2.5 complete cycles to achieve a live birth. Those who have realistic expectations about the number of cycles tend to have less anxiety and more stable physical condition.
• Male semen quality is underestimated. Partners of women aged 35-40 are often the same age, and male sperm DNA fragmentation index (DFI) increases with age. When DFI > 20%, even if the embryo is chromosomally normal, it can affect blastocyst development and implantation. Thai doctors now place increasing importance on male DFI testing.
• Continuity of luteal phase support after returning home. After embryo transfer in Thailand and returning home, the continuity of the luteal phase support plan is a common blind spot. Progesterone preparations differ between countries, and improper switching can lead to insufficient luteal phase support, affecting implantation. It is recommended to ask the doctor for a detailed medication transition plan before leaving Thailand.

Risk Reminder (Conclusion)

Risk Reminder: How to View Success Rate Numbers & Individual Decisions

The IVF success rate in Thailand for ages 35-40 is a population-based statistical concept and cannot be directly mapped to an individual. A truly effective decision-making path is:

1. Complete a full fertility workup (AMH, FSH, AFC, thyroid function, Vitamin D, male DFI).
2. Based on the results, have a reproductive doctor assess whether you have a "normal ovarian response," "mild decline," or "significant decrease."
3. Based on the assessment, choose a corresponding stimulation protocol (long protocol, antagonist protocol, mild stimulation, or natural cycle).
4. Combine with your history of previous pregnancies, miscarriages, and chromosomal status to decide whether to undergo PGT-A.
5. Based on the results of the first cycle, dynamically adjust the subsequent strategy.

The role of success rate data is to establish a reasonable range of expectations, not to be the sole criterion for choosing a hospital. For the 35-40 age group, the biggest risk is not a low success rate, but decision-making bias caused by information asymmetry—such as mistakenly believing that "IVF success rates in Thailand are far higher than in China," or that "PGT-A can solve all age-related problems."

Compilation of Frequently Asked Questions

Brief Answers to Frequently Asked Questions

• Can I still go to Thailand for IVF if my AMH is low? Yes, but you need to adjust your expectations. When AMH < 0.8 ng/mL, the number of eggs retrieved is usually less than 5. Mild stimulation or natural cycles are recommended, and 2–3 cycles may be needed to accumulate embryos.
• What documents are needed for IVF in Thailand? Passport (valid for more than 6 months), notarized and translated marriage certificate, visa (medical visa or tourist visa, depending on hospital requirements). Some hospitals require the original notarized marriage certificate.
• How long does PGT-A take for ages 35-40 in Thailand? One complete cycle (tests + stimulation + egg retrieval + blastocyst culture + PGT-A + frozen embryo transfer) takes about 2.5–4 months, with the stay in Thailand being approximately 20–28 days (split into two trips: 15–18 days for stimulation and egg retrieval, 5–7 days for transfer).
• Does the male partner have to go to Thailand? Yes, he must be present on the day of egg retrieval to provide a semen sample. If he cannot go, semen can be frozen in advance in your home country and transported to Thailand, but you must confirm if the hospital accepts cross-border sperm transport.
• Is preparation needed before IVF in Thailand? It is recommended to start taking Coenzyme Q10, Vitamin D, and folic acid at least 2–3 months in advance, along with weight control and regular sleep. For men, supplementing with zinc, selenium, and L-carnitine is recommended to reduce DNA fragmentation.